How improved transparency and guidance within a complex system can improve consumer health literacy

States can influence how health care is delivered to their citizens

By understanding how biologics are developed, actuaries can help manage this growing area of cost

Solutions to help manage the cost of specialty drugs for gene and cell therapies

What can be done to address common loopholes

A solution to better align drug prices with clinical benefits

Drug access and transparency are prioritized while cost takes a back seat

There are many costs (and steps) to bring a drug to market

A spoonful of strategy helps the governance go down

Actuaries can play a key role in insurance product design and regulation